Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Oct. 28, 2023	Oct. 29, 2022
Operating activities
Net earnings	$ 781.0	$ 924.0
Adjustments to reconcile net earnings to total cash provided by (used in) operating activities:
Depreciation and amortization	702.0	679.0
Restructuring charges	(16.0)	61.0
Stock-based compensation	110.0	98.0
Gain on sale of subsidiary, net	(21.0)
Other, net	7.0	19.0
Changes in operating assets and liabilities:
Receivables	240.0	(14.0)
Merchandise inventories	(2,444.0)	(1,365.0)
Other assets	(17.0)	(1.0)
Accounts payable	1,468.0	224.0
Income taxes	(200.0)	28.0
Other liabilities	(320.0)	(761.0)
Total cash provided by (used in) operating activities	290.0	(108.0)
Investing activities
Additions to property and equipment	(612.0)	(696.0)
Purchases of investments	(7.0)	(46.0)
Net proceeds from sale of subsidiary	14.0
Other, net	5.0	6.0
Total cash used in investing activities	(600.0)	(736.0)
Financing activities
Repurchase of common stock	(270.0)	(465.0)
Dividends paid	(603.0)	(595.0)
Other, net	1.0	2.0
Total cash used in financing activities	(872.0)	(1,058.0)
Effect of exchange rate changes on cash and cash equivalents	(12.0)	(10.0)
Decrease in cash, cash equivalents and restricted cash	(1,194.0)	(1,912.0)
Cash, cash equivalents and restricted cash at beginning of period	2,253.0	3,205.0
Cash, cash equivalents and restricted cash at end of period	$ 1,059.0	$ 1,293.0